Sensus Healthcare, Inc. (SRTS)
USD 4.45
(-9.29%)
USD 4.45
(-9.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 24.4 Million USD | -45.2% |
| 2022 | 44.53 Million USD | 64.68% |
| 2021 | 27.04 Million USD | 182.37% |
| 2020 | 9.57 Million USD | -64.87% |
| 2019 | 27.26 Million USD | 3.16% |
| 2018 | 26.42 Million USD | 28.36% |
| 2017 | 20.58 Million USD | 39.0% |
| 2016 | 14.81 Million USD | 44.17% |
| 2015 | 10.27 Million USD | 76.81% |
| 2014 | 5.81 Million USD | -44.55% |
| 2013 | 10.47 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 9.23 Million USD | -13.35% |
| 2024 Q1 | 10.66 Million USD | -15.14% |
| 2023 Q4 | 12.56 Million USD | 222.37% |
| 2023 Q1 | 3.41 Million USD | -73.95% |
| 2023 Q2 | 4.52 Million USD | 32.6% |
| 2023 Q3 | 3.89 Million USD | -13.89% |
| 2023 FY | 24.4 Million USD | -45.2% |
| 2022 Q3 | 9.01 Million USD | -25.41% |
| 2022 Q4 | 13.1 Million USD | 45.45% |
| 2022 FY | 44.53 Million USD | 64.68% |
| 2022 Q1 | 10.33 Million USD | -20.63% |
| 2022 Q2 | 12.08 Million USD | 16.85% |
| 2021 Q4 | 13.02 Million USD | 135.75% |
| 2021 Q3 | 5.52 Million USD | 1.9% |
| 2021 Q2 | 5.42 Million USD | 76.61% |
| 2021 FY | 27.04 Million USD | 182.37% |
| 2021 Q1 | 3.07 Million USD | -39.74% |
| 2020 Q2 | 1.18 Million USD | -29.56% |
| 2020 FY | 9.57 Million USD | -64.87% |
| 2020 Q4 | 5.09 Million USD | 214.44% |
| 2020 Q3 | 1.62 Million USD | 36.96% |
| 2020 Q1 | 1.67 Million USD | -80.26% |
| 2019 Q4 | 8.5 Million USD | 45.69% |
| 2019 FY | 27.26 Million USD | 3.16% |
| 2019 Q2 | 7.47 Million USD | 37.52% |
| 2019 Q3 | 5.84 Million USD | -21.87% |
| 2019 Q1 | 5.43 Million USD | -32.72% |
| 2018 Q4 | 8.08 Million USD | 27.58% |
| 2018 FY | 26.42 Million USD | 28.36% |
| 2018 Q1 | 5.95 Million USD | -7.95% |
| 2018 Q2 | 6.05 Million USD | 1.7% |
| 2018 Q3 | 6.33 Million USD | 4.58% |
| 2017 Q3 | 4.79 Million USD | -3.47% |
| 2017 Q2 | 4.96 Million USD | 14.1% |
| 2017 Q1 | 4.35 Million USD | -10.72% |
| 2017 Q4 | 6.46 Million USD | 34.91% |
| 2017 FY | 20.58 Million USD | 39.0% |
| 2016 Q1 | 3.03 Million USD | -20.97% |
| 2016 Q2 | 3.57 Million USD | 17.65% |
| 2016 Q3 | 3.32 Million USD | -6.81% |
| 2016 FY | 14.81 Million USD | 44.17% |
| 2016 Q4 | 4.87 Million USD | 46.56% |
| 2015 Q3 | 2.1 Million USD | -12.02% |
| 2015 Q1 | 1.92 Million USD | 0.0% |
| 2015 FY | 10.27 Million USD | 76.81% |
| 2015 Q4 | 3.84 Million USD | 82.23% |
| 2015 Q2 | 2.39 Million USD | 24.14% |
| 2014 FY | 5.81 Million USD | -44.55% |
| 2013 FY | 10.47 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -102.38% |
| BrainsWay Ltd. | 31.78 Million USD | 23.218% |
| Cerus Corporation | 156.36 Million USD | 84.392% |
| Envoy Medical, Inc. | 316 Thousand USD | -7623.101% |
| electroCore, Inc. | 16.03 Million USD | -52.246% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -3689.596% |
| IceCure Medical Ltd | 3.22 Million USD | -655.807% |
| Inogen, Inc. | 315.66 Million USD | 92.269% |
| OrthoPediatrics Corp. | 148.73 Million USD | 83.591% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -905.148% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -6586.32% |
| MaxCyte, Inc. | 41.28 Million USD | 40.891% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -1149.974% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -21936.515% |
| Orthofix Medical Inc. | 746.64 Million USD | 96.731% |
| PAVmed Inc | 2.45 Million USD | -895.31% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -8.375% |
| RxSight, Inc. | 89.07 Million USD | 72.602% |
| Sight Sciences, Inc. | 81.05 Million USD | 69.891% |
| SI-BONE, Inc. | 138.88 Million USD | 82.428% |
| TELA Bio, Inc. | 58.45 Million USD | 58.249% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 86.957% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -76.835% |
| Acutus Medical, Inc. | 7.16 Million USD | -240.662% |
| Talis Biomedical Corporation | 412 Thousand USD | -5823.544% |
| Spectral AI, Inc. | 18.05 Million USD | -35.163% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -146.391% |
| CVRx, Inc. | 39.29 Million USD | 37.893% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -2419.34% |
| Bioventus Inc. | 512.34 Million USD | 95.237% |
| Venus Concept Inc. | 76.35 Million USD | 68.037% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -31.841% |
| LivaNova PLC | 1.15 Billion USD | 97.884% |
| 908 Devices Inc. | 50.22 Million USD | 51.413% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 94.939% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -31576.704% |
| NeuroPace, Inc. | 65.42 Million USD | 62.695% |
| LENSAR, Inc. | 42.16 Million USD | 42.119% |
| Apyx Medical Corporation | 52.34 Million USD | 53.38% |
| Cutera, Inc. | 212.36 Million USD | 88.508% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 26.839% |
| BioSig Technologies, Inc. | 18 Thousand USD | -135483.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 85.357% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -1.879% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 98.417% |
| Axonics, Inc. | 366.37 Million USD | 93.339% |
| Outset Medical, Inc. | 130.37 Million USD | 81.281% |
| IRIDEX Corporation | 51.86 Million USD | 52.949% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 82.08% |
| IRadimed Corporation | 65.56 Million USD | 62.776% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -1975.255% |
| INVO Bioscience, Inc. | 3.02 Million USD | -707.959% |
| Telesis Bio, Inc. | 27.5 Million USD | 11.284% |
| Viemed Healthcare, Inc. | 183 Million USD | 86.665% |
| Varex Imaging Corporation | 811 Million USD | 96.991% |
| Quipt Home Medical Corp. | 221.74 Million USD | 88.994% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 64.463% |
| Dynatronics Corporation | 32.53 Million USD | 24.986% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -181.228% |
| Semler Scientific, Inc. | 68.18 Million USD | 64.207% |
| InMode Ltd. | 492.04 Million USD | 95.04% |
| Bruker Corporation | 2.96 Billion USD | 99.177% |
| Cytosorbents Corporation | 36.34 Million USD | 32.86% |
| DexCom, Inc. | 3.62 Billion USD | 99.326% |
| Align Technology, Inc. | 3.86 Billion USD | 99.368% |
| Viveve Medical, Inc. | 6.42 Million USD | -279.785% |
| ZimVie Inc. | 457.43 Million USD | 94.665% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 87.356% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -21936.515% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 96.736% |
| Profound Medical Corp. | 7.33 Million USD | -232.9% |
| Insulet Corporation | 1.69 Billion USD | 98.562% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 80.643% |
| iCAD, Inc. | 17.31 Million USD | -40.923% |
| Nuwellis, Inc. | 8.86 Million USD | -175.327% |
| Biotricity, Inc. | 12.06 Million USD | -102.307% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 95.046% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -293.312% |
| PAVmed Inc. | 2.45 Million USD | -895.31% |
| BIOLASE, Inc. | 49.16 Million USD | 50.36% |
| Beyond Air, Inc. | 1.15 Million USD | -2005.695% |
| FONAR Corporation | 102.88 Million USD | 76.279% |
| AxoGen, Inc. | 159.01 Million USD | 84.652% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 91.107% |
| Inari Medical, Inc. | 493.63 Million USD | 95.056% |
| UFP Technologies, Inc. | 400.07 Million USD | 93.9% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -131109.677% |
| Tenon Medical, Inc. | 2.92 Million USD | -733.504% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -258.263% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.237% |
| Sintx Technologies, Inc. | 2.62 Million USD | -829.006% |
| NanoVibronix, Inc. | 2.28 Million USD | -968.988% |
| Quanterix Corporation | 122.36 Million USD | 80.056% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 87.829% |
| TransMedics Group, Inc. | 241.62 Million USD | 89.9% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -76.159% |
| NeuroMetrix, Inc. | 5.9 Million USD | -313.544% |
| Hyperfine, Inc. | 11.03 Million USD | -121.22% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 85.223% |
| Biomerica, Inc. | 5.41 Million USD | -350.693% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 51.732% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 86.222% |